[Multiplication of viruses. 2. Future of antiviral chemotherapy].
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004261:DNA Replication; D004279:DNA, Viral / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D051379:Mice; D010396:Penicillamine / Q000494:pharmacology; D012316:RNA Nucleotidyltransferases / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D012265:Ribonucleotides / Q000494:pharmacology; D012270:Ribosomes / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D001562:Benzimidazoles; D004279:DNA, Viral; D007546:Isoquinolines; D012367:RNA, Viral; D012265:Ribonucleotides; D007372:Interferons; D004254:DNA Nucleotidyltransferases; D012316:RNA Nucleotidyltransferases; D010396:Penicillamine; D012293:Rifampin
La multiplication des virus. 2. Perspectives d'avenir de la chimiothérapie antivirale.